✦ LIBER ✦

Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhage

✍ Scribed by R. RISSELADA; H. STRAATMAN; F. VAN KOOTEN; D. W. J. DIPPEL; A. VAN DER LUGT; W. J. NIESSEN; A. FIROUZIAN; R. M. C. HERINGS; M. C. J. M. STURKENBOOM

Book ID: 109154622
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 140 KB
Volume: 9
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2010.04170.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dietary antioxidant intake and risk of a

Dietary antioxidant intake and risk of an aneurysmal rupture subarachnoid hemorrhage in Japan

✍ Okamoto, K; Horisawa, R 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

Continuous determination of platelet agg

Continuous determination of platelet aggregation during acute hemorrhage in the arterial and venous system of dogs

✍ K. U. Benner; K. E. Frede 📂 Article 📅 1971 🏛 Springer 🌐 English ⚖ 428 KB

The relationship between ABO blood group

The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

✍ A. A. GARCIA; J. F. VAN DER HEIJDEN; J. C. M. MEIJERS; F. R. ROSENDAAL; P. H. RE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

ChemInform Abstract: Asymmetric Synthesi

ChemInform Abstract: Asymmetric Synthesis: Application to the Synthesis of a Platelet Aggregation Inhibitor and an M3 Muscarinic Receptor Antagonist

✍ Janine Cossy 📂 Article 📅 2001 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

Inherited deficiency of multiple vitamin

Inherited deficiency of multiple vitamin K-dependent coagulation factors and coagulation inhibitors presenting as hemorrhagic diathesis, mental retardation, and growth retardation

✍ Ghosh, Kanjaksha; Shetty, Shrimati; Mohanty, Dipika 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

All of these factors were determined by one-stage assay using standard technique. Prothrombin by two-stage assay was 12%. Screening forcoagulation inhibitors was negative. Protein C antigen [74% (normal, 70-140 by enzyme-linked immunosorbent assay], protein C 146% by chromogenic assay (normal, 70-14

Pharmacokinetic, bioavailability and pha

Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man

✍ L. M. Fuccella; G. Corvi; E. Moro; E. Pogliani; V. Tamassia; G. Tosolini 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 439 KB